Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Piper Sandler issued their Q1 2023 earnings estimates for shares of Aptose Biosciences in a report released on Tuesday, March 22nd. Piper Sandler analyst E. Tenthoff anticipates that the biotechnology company will earn ($0.16) per share for the quarter. Piper Sandler also issued […]
Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Stock analysts at Oppenheimer issued their Q1 2022 earnings estimates for shares of Aptose Biosciences in a research note issued to investors on Wednesday, March 23rd. Oppenheimer analyst M. Biegler expects that the biotechnology company will post earnings per share of ($0.13) for the quarter. Oppenheimer […]